Cormorant Asset Management, LP Sorrento Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $1.86 Million - $2.89 Million	-400,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $741,000 - $1.1 Million	-100,000 Reduced 20.0%	400,000 $3.05 Million
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $14.3 Million - $22.5 Million	-2,250,000 Reduced 81.82%	500,000 $4.85 Million
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $12.3 Million - $28.9 Million	-1,750,000 Reduced 38.89%	2,750,000 $22.7 Million
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $8.64 Million - $17.9 Million	-1,500,000 Reduced 25.0%	4,500,000 $30.7 Million

Q3 2020 Nov 16, 2020	SELL	$6.17 - $18.82 $3.09 Million - $9.41 Million	-500,000 Reduced 7.69%	6,000,000 $66.9 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $2.6 Million - $10.1 Million	1,500,000 Added 30.0%	6,500,000 $40.8 Million
Q1 2020 May 15, 2020	BUY	$1.57 - $4.76 $1.57 Million - $4.76 Million	1,000,000 Added 25.0%	5,000,000 $9.2 Million
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $5.8 Million - $16.7 Million	4,000,000 New	4,000,000 $13.5 Million

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.